Bloomage Biotech(SH:688363) Xin Hua Cai Jing·2025-11-08 03:04Core Viewpoint - The eighth China International Import Expo has showcased Huaxi Biological's innovative solutions in anti-aging based on extracellular matrix (ECM) science, highlighting China's strength in life sciences innovation [1] Group 1: ECM Scientific Layout - Huaxi Biological maintains a systematic scientific layout of ECM, aligning with global life science frontiers, with ECM changes recognized as a major aging marker by 2025 [3] - The company actively participates in ECM research, focusing on key components like hyaluronic acid and collagen, transitioning from a "single substance era" to a "system structure era" in anti-aging research [3] - Huaxi Biological's research system integrates glycomics and cell biology, utilizing a 30 billion-level molecular database and AI R&D platform for multi-scale research and engineering applications [3] Group 2: Global Research and Industry Application - The company's active substances are widely adopted by global Fortune 500 companies and top research institutions, contributing to ECM signal communication and regeneration mechanism studies [5] Group 3: Innovation and Manufacturing Capabilities - At the Import Expo, Huaxi Biological showcased innovative products derived from ECM research, leveraging China's manufacturing capabilities and a leading pilot transformation platform with 64 pilot production lines [6] - The company has received multiple domestic and international awards for its raw material research, exemplifying the effective transformation of cutting-edge research into market results [9] Group 4: Transition from Manufacturing to Standard Setting - Huaxi Biological is transitioning from "technology output" to "standard leadership," establishing a global intellectual property protection network through PCT patents in over 30 countries [9] - The company plans to build a regional center in Europe for "nearshore manufacturing" to quickly respond to global market demands [9] Group 5: Product Development and Medical Applications - The company's product lines, such as Runbaiyan, demonstrate the ability to rebuild healthy ECM networks, while Huaxi Dangkang nutrition products reflect a systemic anti-aging approach [10] - Huaxi Biological has obtained 11 Class III medical device certificates for aesthetic injection products, with the latest technology capable of rejuvenating skin by restoring ECM structure [10] Group 6: Milestone Achievements - Huaxi Biological has established the international standard for hyaluronic acid (ISO 22718), breaking the monopoly of Western companies on bioactive substance standards, marking a significant shift in the company's role [12] - The company aims to enhance China's influence in global life sciences through leading-edge research and industry ecosystem construction, signaling the start of a new cycle in systemic anti-aging [12]